from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1531/-

LFCtreatmentdescriptionclass of inhibitor

-0.259

Amikacinug/mL Amikacintranslation

-0.032

Cap5-10ug/mL Capreomycintranslation

-1.540

Rox10-50 ug/mL Roxithromycintranslation

-0.071

SM2-5 ug/mL Streptomycintranslation

0.696

Tet5-10 ug/mL Tetracyclinetranslation

0.620

Rif0.2-5ug/mL Rifampicintranscription

-0.637

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.170

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.319

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.549

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.619

Clofazimine10-13 ug/mL Clofaziminerespiration

1.645

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.308

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.082

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.173

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.957

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.407

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.220

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.020

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.612

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.469

KCN5-20 ug/mL Potassium cyaniderespiration

-0.463

NaN30.2-2 mM Sodium aziderespiration

-1.312

Nigericin50 uM Nigericinrespiration

-0.045

TRC10-150 ug/mL Triclosanrespiration

0.919

TRZ10-25 ug/mL Thioridazinerespiration

-1.159

Valinomycin0.5-10 uM Valinomycinrespiration

2.263

ZnSO42 mM ZnSO4respiration

-0.374

menadione6-10 ug/mL Menadionerespiration

0.659

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.174

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.317

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.955

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.391

NRP_1Non-replicating persistence stage 1dosRassociated

-0.104

Amp0.2mg/mL AmpicillincellWall

-0.290

Cephalexin20-100 ug/mL CephalexincellWall

-0.143

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.134

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.140

EMB10-20 ug/mL EthambutolcellWall

-0.360

Eta12-40 ug/mL EthionamidecellWall

-0.494

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.072

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.030

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.755

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.181

BZA0.12 mg/mL BenzamidearomaticAmides

0.083

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.457

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.320

H2O24 mM hydrogen peroxideDNAdamaging

-0.195

Levo10 ug/mL LevofloxacinDNAdamaging

0.199

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.557

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.295

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.119

UVUV-irradiationDNAdamaging

-1.405

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.088

Antimycin12.5-50 ug/mL Antimycin A?

-0.511

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.162

PA_110-50 ug/mL Antitubercular compound PA-1?

0.019

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.061

PA8240.2-2 ug/mL PA-824?

0.268

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.464

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.597

Verapamil50 uM Verapamil?

-0.559

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.031

methoxatin10-20 ug/mL Methoxatin?